Robert W. Baird Boosts Longboard Pharmaceuticals (NASDAQ:LBPH) Price Target to $60.00
Longboard Pharmaceuticals (NASDAQ:LBPH – Free Report) had its target price hoisted by Robert W. Baird from $36.00 to $60.00 in a research report report published on Thursday morning, Benzinga reports. They currently have an outperform rating on the stock. Other research analysts have also issued reports about the company. B. Riley upped their price target […]
More Stories
Fidelity MSCI Consumer Staples Index ETF (NYSEARCA:FSTA) Sees Large Volume Increase – Should You Buy?
Fidelity MSCI Consumer Staples Index ETF (NYSEARCA:FSTA – Get Free Report) saw unusually-high trading volume on Monday . Approximately 226,709...
Voya Financial (NYSE:VOYA) Reaches New 1-Year High – Still a Buy?
Shares of Voya Financial, Inc. (NYSE:VOYA – Get Free Report) hit a new 52-week high on Monday . The company...
Children face unprecedented crisis amid rising violence in Haiti
This year has seen a staggering 1,000 per cent or ten-fold surge in sexual violence against children in Haiti, during...
iShares High Yield Bond Factor ETF (BATS:HYDB) Hits New 52-Week Low – Here’s What Happened
iShares High Yield Bond Factor ETF (BATS:HYDB – Get Free Report)’s stock price hit a new 52-week low during mid-day...
Holcim (OTCMKTS:HCMLY) Hits New 12-Month High – What’s Next?
Holcim AG (OTCMKTS:HCMLY – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Monday ....
iShares U.S. Home Construction ETF (BATS:ITB) Hits New 52-Week High – Here’s Why
iShares U.S. Home Construction ETF (BATS:ITB – Get Free Report)’s share price hit a new 52-week high during mid-day trading...